US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Femtech Market Industry Trends and Forecast to 2034: Segmented by (Type, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $13.86 Bn.
Canada at 14% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$25.19 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $12.35 Bn | — | — |
| 2025 (base) | $13.86 Bn | +$1.51 Bn | — |
| 2026 (forecast) | $15.55 Bn | +$1.69 Bn | +12.2% |
| 2027 (forecast) | $17.44 Bn | +$1.90 Bn | +25.9% |
| 2028 (forecast) | $19.57 Bn | +$2.13 Bn | +41.2% |
| 2029 (forecast) | $21.96 Bn | +$2.39 Bn | +58.5% |
| 2030 (forecast) | $24.64 Bn | +$2.68 Bn | +77.8% |
| 2031 (forecast) | $27.64 Bn | +$3.01 Bn | +99.5% |
| 2032 (forecast) | $31.02 Bn | +$3.37 Bn | +123.8% |
| 2033 (forecast) | $34.80 Bn | +$3.78 Bn | +151.2% |
| 2034 (forecast) | $39.05 Bn | +$4.25 Bn | +181.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$13.86 Bn
China
$3.37 Bn
Canada
$3.05 Bn
Japan
$2.06 Bn
Germany
$1.15 Bn
France
$1.12 Bn
UK
$952.3 Mn
Italy
$872.1 Mn
Ecuador
$804.7 Mn
Brazil
$788.0 Mn
Saudi Arabia
$718.3 Mn
India
$666.9 Mn
Spain
$604.7 Mn
Mexico
$611.9 Mn
Russia
$400.9 Mn
Australia
$406.1 Mn
New Zealand
$352.7 Mn
South Africa
$273.6 Mn
UAE
$190.6 Mn
Egypt
$104.5 Mn
Philippines
$87.3 Mn
Malaysia
$64.0 Mn
Hong Kong
$52.0 Mn
Singapore
$44.2 Mn
Thailand
$38.2 Mn
Kenya
$22.6 Mn
| Market size, 2025 | $13.86 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $39.05 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, product and end user (see all) |
| Key players | Flo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and 1 more (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Femtech covers apps, devices and services built for women's health, from period tracking to fertility, pregnancy, menopause and pelvic health.
Key segments of the femtech market include type (Period and Fertility Tracking, Pregnancy and Nursing Care and Pelvic Health) and product (Apps, Wearables and Connected Devices).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the femtech market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the femtech market.
The femtech market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA regulates software that works as a medical device, and runs a Digital Health Center of Excellence.[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the femtech market. Government digital health programs in US are speeding up adoption.
What doctors and scientists are doing in Femtech right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Medical Devices · US
Pharmaceuticals · US
Pharmaceuticals · US